[en] 8-Epi-PGF2alpha, a prostaglandin-like compound generated by oxidative stress, has been shown to be an in vitro bronchoconstrictor in airways from healthy laboratory animals and healthy humans, but it has never been studied in diseased airways. Here, the bronchoconstrictive capacity of 8-epi-PGF2alpha on isolated bronchial rings (BR) of healthy and heaves-affected horses was evaluated by comparing the maximal effect and the potency of 8-epi-PGF2alpha to those of (1) acetylcholine (ACh), (2) its stereoisomer PGF2alpha and (3) its synthetic receptor agonist, U46619. Furthermore, the potential capacity of 8-epi-PGF2alpha to enhance the cholinergic (ACh) responsiveness of bronchial smooth muscle was investigated. 8-Epi-PGF2alpha contracted BR with a rank order of efficacy of Ach > U44619 > PGF2alpha > 8-epi-PGF2alpha in both healthy and heaves-affected horses. The contractile maximal response elicited by 8-epi-PGF2alpha was significantly smaller than that elicited by the other drugs, but was significantly higher in BR from heaves-affected horses than in those sampled in healthy horses, whilst pD2 values were similar. A subthreshold concentration of 8-epi-PGF2alpha (10-7 M) did not induce in vitro cholinergic hyper-responsiveness in BR of either healthy or heaves-affected horses. In conclusion, it has been demonstrated that 8-epi-PGF2alpha is an in vitro bronchoconstrictor of minor importance in healthy horses, but whose efficacy is significantly increased in heaves-affected horses.
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Kirschvink, Nathalie
Art, Tatiana ; Université de Liège - ULiège > Département de sciences fonctionnelles > Phys. neuro-muscul., de l'effort - Méd. sport. des animaux
Lekeux, Pierre ; Université de Liège - ULiège > Département de sciences fonctionnelles > Physiologie
Roberts, C.
Gustin, Pascal ; Université de Liège - ULiège > Département de sciences fonctionnelles > Pharmacologie, pharmacothérapie et toxicologie
Language :
English
Title :
Effects of 8-epi-Pgf2alpha on isolated bronchial smooth muscle of healthy and heaves-affected horses
Publication date :
2001
Journal title :
Journal of Veterinary Pharmacology and Therapeutics
Armour C., Johnson P., Anticevich S., Ammit A., McKay K., Hughes M., Black J. (1997) Mediators on human airway smooth muscle. Clinical and Experimental Pharmacology and Physiology 24:269-272.
Art T., Kirschvink N., Smith N., Lekeux P. (1999) Indices of oxidative stress in blood and pulmonary epithelial lining fluid in horses suffering from recurrent airway obstruction. Equine Veterinary Journal 31:397-401.
Banerjee M., Kang K.H., Morrow J.D., Roberts L.J., Newman J.H. (1992) Effects of a novel prostaglandin, 8-epi-PCF2α, in rabbit lung in situ. American Journal of Physiology 263.
Barnes P.J. (1998) Pharmacology of airway smooth muscle. American Journal of Respiratory and Critical Care Medicine 158.
Barnes P.J., Chung K.F., Page C.P. (1998) Inflammatory mediators of asthma: An update. Pharmacological Reviews 50:515-596.
Bousquet J., Jeffery P.K., Busse W.W., Johnson M., Vignola A.M. (2000) Asthma: From bronchoconstriction to airways inflammation and remodeling. American Journal of Respiratory and Critical Care Medicine 161:1720-1745.
Doucet M.Y., Jones T.R., Ford-Hutchinson A.W. (1990) Responses of equine trachealis and lung parenchyma to methacholine, histamine, serotonin, prostanoids, and leukotrienes in vitro. Canadian Journal of Physiology and Pharmacology 68:379-383.
Dworski R., Murray J.J., Roberts II L.J., Oates J.A., Morrow J.D., Fisher L., Sheller J.R. (1999) Allergen-induced synthesis of F2-isoprostanes in atopic asthmatics. Evidence for oxidant stress. American Journal of Respiratory and Critical Care Medicine 160:1947-1951.
Elmhurst J.L., Betti P.-A., Rangachari P.R. (1997) Intestinal effects of isoprostanes: Evidence for the involvement of prostanoid EP and TP receptors. Journal of Pharmacology and Experimental Therapeutics 282:1198-1205.
Fukunaga M., Yura T., Grygorczyk R., Badr K.F. (1997) Evidence for the distinct nature of F2-isoprostane receptors from those of thromboxane A2. American Journal of Physiology 272.
Gray P.R., Derksen F.J., Robinson N.E., Carpenter-Deyo L.J., Johnson H.G., Roth R.A. (1989) The role of cyclooxygenase products in the acute airway obstruction and airway hyperreactivity of ponies with heaves. American Review of Respiratory Disease 140:154-160.
Jongejan R.C., De Jongste J.C., Raatgeep R.C., Stijnen T., Bonta I.L., Kerrebijn K.F. (1990) Effects of inflammatory mediators on the responsiveness of isolated human airways to methacholine. American Review of Respiratory Disease 142:1129-1132.
Kang K.H., Morrow J.D., Roberts II L.J., Newman H.J., Banerjee M. (1993) Airway and vascular effects of 8-epi-prostaglandin F2α in isolated perfused rat lung. Journal of Applied Physiology 74:460-465.
Kaup F.-J., Drommer W., Damsch S., Deegen E. (1990) Ultrastructural findings in horses with chronic obstructive pulmonary disease (COPD). II: Pathomorphological changes in the terminal airways and the alveolar region. Equine Veterinary Journal 22:349-355.
Kawikova I., Barnes P.J., Takahashi T., Tadjkarimi S., Yacoub M.H., Belvisi M.G. (1996) 8-Epi-PGF2α, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. American Journal of Respiratory and Critical Care Medicine 153:590-596.
Kirschvink N., Art T., Smith N., Lekeux P. (1999) Effect of exercise and COPD crisis on isoprostane concentration in plasma and bronchoalveolar lavage fluid in horses. Equine Veterinary Journal of Supplement 30:88-91.
Lawson J.A., Rokach J., FitzGerald G.A. (1999) Isoprostanes: Formation, analysis and use as indices of lipid peroxidation in vivo. Journal of Biological Chemistry 274:24441-24444.
LeBlanc P.H., Broadstone R.V., Derksen F.J., Robinson N.E. (1991) In vitro responses of distal airways in horses with recurrent airway obstruction. American Journal of Veterinary Research 52:999-1003.
Montuschi P., Ciabattoni G., Paredi P., Pantelidis P., Du Bois R.M., Kharitonov S.A., Barnes P.J. (1998) 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. American Journal of Respiratory and Critical Care Medicine 158:1524-1527.
Montuschi P., Corradi M., Ciabattoni G., Nightingale J., Kharitonov S.A., Barnes P.J. (1999) Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. American Journal of Respiratory and Critical Care Medicine 160:216-220.
Morrow J.D., Roberts II L.J. (1996) The isoprostanes. Current knowledge and directions for future research. Biochemical Pharmacology 51:1-9.
Pratico D., Basili S., Vieri M., Cordova C., Violi F., FitzGerald G.A. (1998) Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2αIII, an index of oxidant stress. American Journal of Respiratory and Critical Care Medicine 158:1709-1714.
Roberts II L.J., Morrow J.D. (2000) Measurement of F2-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine 28:505-513.
Robinson N.E., Derksen F.J., Olszewski M.A., Buechner-Maxwell V.A. (1996) The pathogenesis of chronic obstructive pulmonary disease of horses. British Veterinary Journal 152:283-305.
Yu M.F., Wang Z.W., Robinson N.E., Derksen F.J. (1994) Modulation of bronchial smooth muscle function in horses with heaves. Journal of Applied Physiology 77:2149-2154.